Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial
Thomas Powles, Srikala S. Sridhar, Yohann Loriot, Joaquim Bellmunt, Xinmeng Jasmine Mu, Keith A. Ching, Jie Pu, Cora N. Sternberg, Daniel P. Petrylak, Rosa Tambaro, Louis Marie Dourthe, Carlos Álvarez-Fernández, Maureen J.B. Aarts, Alessandra di Pietro, Petros Grivas, Craig B. Davis
Topics & Concepts
JavelinAvelumabUrothelial carcinomaMetastatic Urothelial CarcinomaBiomarkerMedicineBladder cancerOncologyCarcinomaUrothelial cancerInternal medicineUrologyImmunotherapyCancerChemistryNivolumabEngineeringMechanical engineeringBiochemistryThrowingBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and BiomarkersUrinary and Genital Oncology Studies